Showing results (2011-2020 of 2,377) with videos related to
Sort By:
Pageof 238
The Breast Journal|July 19, 2012
Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breastAlan B Hollingsworth, Rebecca G StoughThe Breast Journal|September 26, 2012
Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and NorwayPål Suhrke, Jan Mæhlen, Per-Henrik ZahlThe Breast Journal|October 20, 2012
Is screening detected bilateral axillary adenopathy on mammography clinically significant?Alison Chetlen, Brandi Nicholson, James T Patrie, et al.The Breast Journal|July 26, 2012
Self-reported cognitive impairment after breast cancer treatment in young women from the ELIPPSE40 cohort: the long-term impact of chemotherapyDominique Rey, Anne-Déborah Bouhnik, Julien Mancini, et al.The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.The Breast Journal|August 14, 2012
Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35Aziza Nassar, Zachary M Sussman, Diane Lawson, et al.The Breast Journal|August 14, 2012
Breast-related CSF shunt complications: literature review with illustrative caseRudolph J Schrot, Christine Ramos-Boudreau, James E BogganThe Breast Journal|May 6, 2004
Bone marrow micrometastases and adjuvant treatment of breast cancerJeanne J Yu, Meghan Brennan, Paul Christos, et al.The Breast Journal|May 6, 2004
Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancerJane S Blake-Mortimer, Sandra E Sephton, Robert W Carlson, et al.The Breast Journal|May 6, 2004
The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal womenAman U Buzdar, Ignace Vergote, Richard SainsburyPageof 238